Graduate School of Biomedical Sciences Archives - Page 2 of 2 - Sanford Burnham Prebys
Institute News

Advocating for science

AuthorChristine Infante
Date

April 26, 2018

On April 24, Jennifer Zeitzer, director of legislative relations/deputy director, Office of Public Affairs at the Federation of American Societies for Experimental Biology (FASEB) spoke to Sanford Burnham Prebys Medical Discovery Institute scientists and nonscientists about the importance of getting involved as advocates for science.

“Advocacy is an important part of your role as a scientist,” she said. “It gives back to your professional community.”

Zeitzer went on to cite examples of how effective scientific advocacy has been in recent years. She credits the passing of the Omnibus Appropriations Bill (HR1625) that increased the NIH budget by $3 billion and the NSF budget by $295 million – the largest increases in 15 years – in part at least to advocacy. She also shared that FASEB rallied some 20,000 emails in a short timeframe to preserve tax benefits for graduate students.

A 10-year veteran of FASEB, Zeitzer summarized a few clear action steps that researchers can take to advocate for science: • Be prepared – understand what you want your congressional representative to do

• Do your homework – check congressional members’ websites and social media

• Stay in touch – contact your congress members, understand how they vote (www.congress.gov)

• Make your message effective – tell a personal story, talk about collaborators

Zeitzer encouraged the audience to participate in State Capitol Hill Day and to use the power of electronic media – from emails to social media. “If you don’t speak up, Federal funding will fall off the cliff again,” she said.

The seminar was hosted by SBP’s Office of Education, Training & International Services (OETIS).

To learn more about scientific advocacy or for an overview of online tools and resources go to FASEB’s Science Policy & Advocacy website or contact jzeitzer@faseb.org.

Institute News

Meet the incoming class of 2016!

AuthorJessica Moore
Date

September 15, 2016

Sanford Burnham Prebys Medical Discovery Institute (SBP) welcomes the incoming graduate class of 2016:

Ayako Murao (B.A.Sc., Cal State San Marcos) will explore the mechanisms of cancer progression, especially melanoma, in the lab of Ze’ev Ronai, PhD

Katja Birker (BS, University of British Columbia) is joining the lab of Rolf Bodmer, PhD, where she will study heart development in fruit flies.

Joseph Fromm (BS, UCLA) will work under Nicholas Cosford, PhD, designing small molecule inhibitors of cell death to treat cancer.

Pavel Rhyzov (BS, Bonn-Rhein-Sieg University of Applied Sciences) will probe the structure and function of proteins involved in plague infectivity and cell death in the lab of Francesca Marassi, PhD

Since its launch in 2006, SBP’s Graduate School of Biomedical Sciences (GSBS) has awarded PhD degrees to 27 students who have gone on to careers in both academic research and biotechnology. In 2015 the Western Association of Schools and Colleges (WASC) granted accreditation to the GSBS, a distinction that assures the quality of our resources, policies, and practices to achieve educational goals.

“We’re excited to have these great new graduate students,” said Guy Salvesen, PhD, dean of GSBS and professor in the NCI-designated Cancer Center. “Graduate school can be a long haul, but our program allows students to start their research project immediately so that the average time to degree completion is 4.7 years compared to the national average of 6 years.”

“Our Institute provides access to the most sophisticated minds and technologies in biomedical sciences. There has never been a better time for aspiring scientists to explore careers in biomedical sciences, and SBP’s graduate program provides an outstanding environment to embark on this path,” adds Salvesen.

 

Could you be part of next year’s class? GSBS is accepting applications now.

Institute News

SBP Graduate School of Biomedical Sciences receives WASC accreditation

Authorsgammon
Date

July 30, 2015

Sanford Burnham Prebys Medical Discovery Institute (SBP)  is proud to announce that its Graduate School of Biomedical Sciences has received accreditation by the Western Association of Schools and Colleges (WASC). This is an important milestone for the Graduate School, a distinction that assures the public that our school has the resources, policies, and practices in place to achieve its educational goals.

The SBP Graduate Program began in 2006. Today, we have 25 students with a unique opportunity to carry out their studies in an environment of collaborative research, with access to the most-sophisticated minds and technologies in biomedical sciences. The Program gives graduate students fluency in biology, chemistry, bioinformatics, and engineering to integrate research into meaningful applications that will advance medicine. Their education comes at a time when research has never been more intellectually exciting and critically important to society.

The effort was led by Guy Salvesen, PhD, dean of the Graduate School, who has been dedicated to providing the best learning opportunities for SBP students to become the next-generation of pioneers in biomedical research. Dr. Salveson has overseen the recruitment of talented students from around the world—Europe, Asia, Australia and the United States—and engaged our faculty to teach, train and mentor. He has been accountable to WASC during an eight year systematic process of scrutiny that left no stone unturned. At the same time, he has managed his own research laboratory of staff scientists, postdocs, graduate students and interns, exploring the principles of proteolysis in humans.

In addition to Dr. Salveson, Malene Hansen, PhD, associate dean of Student Affairs; Alessandra Sacco, PhD, associate dean of Curriculum; Robert Rickert, PhD, associate dean of Admissions, and Stacey Smith, manager of the Graduate Program, have helped achieve the goal through their passion for education, and creating an environment that supports the highest-quality learning in biomedical research.

Many congratulations to everyone at SBP that works to support the Graduate School, including the faculty, staff, and the students, for creating and fostering a program that is now officially recognized for its excellence.

Institute News

Targeting protein could improve diagnosis and treatment of lymphoma

AuthorGuest Blogger
Date

January 26, 2015

This post was written by Janelle Weaver, PhD, a freelance writer

Lymphoma is the most common blood cancer in the United States and is responsible for about 20,000 deaths each year. This type of cancer begins in white blood cells called lymphocytes, which normally play an important role in the immune system by recognizing and responding to pathogens such as bacteria and viruses. To control infections, these cells must multiply in a process that depends on a protein called MALT1. But when inappropriately activated, MALT1 drives the survival of lymphoma cells, underscoring the need to monitor the activity of this protein to develop novel diagnostic tests and facilitate drug discovery. Continue reading “Targeting protein could improve diagnosis and treatment of lymphoma”